Product Information
CITALOPRAM HBR 20 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0290 per EA under NDC 69097082307. Its NADAC has been published 519 times since Sep 14, 2016.
FDA first approved this application on Oct 3, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Cipla USA Inc.NDC
69097082307
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CITALOPRAM HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077534FDA Approved
10/3/2006
TE Code
AB
On Market Since
7/22/2016
Pharmacological Classes
Price Statistics
The NADAC for CITALOPRAM HBR 20 MG TABLET has been published 519 times since Sep 14, 2016, and over the history we have for it it has declined 3.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0290 per EA |
|---|---|
| All-time high | $0.0330 (Jun 14, 2017) |
| All-time low | $0.0244 (Nov 20, 2024) |
| 52-week high | $0.0309 |
| 52-week low | $0.0284 |
| Median price | $0.0299 |
| Average price | $0.0299 |
| Largest weekly change | +23.4% (Aug 21, 2024) |
| Weeks tracked | 519 |
| Tracking since | Sep 14, 2016 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CITALOPRAM HBR 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CITALOPRAM HBR 20 MG TABLET, manufactured by Cipla USA Inc., is $0.0290 per EA (NDC 69097082307), effective Aug 19, 2026.
How has the price of CITALOPRAM HBR 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for CITALOPRAM HBR 20 MG TABLET has declined 3.4%. It has been tracked across 519 weekly CMS publications since Sep 14, 2016.
What are the highest and lowest recorded NADAC prices for CITALOPRAM HBR 20 MG TABLET?
Since Sep 14, 2016, the NADAC for CITALOPRAM HBR 20 MG TABLET has ranged from a low of $0.0244 (Nov 20, 2024) to a high of $0.0330 (Jun 14, 2017), with a median of $0.0299 per EA.
Are there cheaper alternatives to CITALOPRAM HBR 20 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CITALOPRAM HBR 20 MG TABLET, is $0.0273 per EA — about 6% below CITALOPRAM HBR 20 MG TABLET.
Who manufactures CITALOPRAM HBR 20 MG TABLET?
CITALOPRAM HBR 20 MG TABLET (NDC 69097082307) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.